Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389

The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047

The orphan receptor GPR55 is a novel cannabinoid receptor

Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315

Agonistic properties of cannabidiol at 5-HT1a receptors

Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878

BONE-MARROW TRANSPLANTATION IN A PATIENT WITH THE WISKOTT-ALDRICH SYNDROME

Bach, F. H., Albertini, R., Joo, P., Anderson, J., & Bortin, M. M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92672-x · Cited by 867

Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants

Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850

Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro

Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 763

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669

Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects

Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608

A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol

Russo, E. B., & Guy, G. W. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 608

Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients

Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R. J., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 570

Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma

Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., PETROCELLIS, L. D., Laezza, C., Portella, G., Bifulco, M., & Marzo, V. D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105247 · Cited by 569

Cannabidiol: An Overview of Some Pharmacological Aspects

Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 530

Cannabidiol—recent advances

Mechoulam, R., Peters, M., Murillo‐Rodriguez, E., & Hanuš, L. O. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790147 · Cited by 515

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression

Carrier, E. J., Auchampach, J. A., & Hillard, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511232103 · Cited by 497

Hashish—I

Mechoulam, R., & Shvo, Y. (1963) · Tetrahedron · doi:10.1016/0040-4020(63)85022-x · Cited by 486

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

Fusar-Poli, P., Crippa, J. A., Bhattacharyya, S., Borgwardt, S. J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S. A., O’Carrol, C., Atakan, Z., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.519 · Cited by 465

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 415

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease

Lastres-Becker, I., Molina-Holgado, F., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.11.009 · Cited by 407

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., & Colleoni, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.006 · Cited by 395

Antianxiety effect of cannabidiol in the elevated plus-maze

Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., & Zuardi, A. W. (1990) · Psychopharmacology · doi:10.1007/bf02244012 · Cited by 379

Effects of ipsapirone and cannabidiol on human experimental anxiety

Zuardi, A. W., Cosme, R. A., Graeff, F. G., & Guimarães, F. S. (1993) · Journal of Psychopharmacology · doi:10.1177/026988119300700112 · Cited by 364

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

Campos, A. C., & Guimarães, F. S. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1168-x · Cited by 364

Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy

Sallan, S. E., Zinberg, N. E., & Frei, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510162931603 · Cited by 364

Neuroprotective effect of cannabidiol, a non‐psychoactive component from Cannabis sativa, on β‐amyloid‐induced toxicity in PC12 cells

Iuvone, T., Esposito, G., Esposito, R., Santamaria, R., Di Rosa, M., & Izzo, A. A. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2003.02327.x · Cited by 361

Chemical Basis of Hashish Activity

Mechoulam, R., Shani, A., Edery, H., & Grunfeld, Y. (1970) · Science · doi:10.1126/science.169.3945.611 · Cited by 331

Controlled clinical trial of cannabidiol in Huntington's disease

Consroe, P. F., Laguna, J., Allender, J. R., Snider, S. R., Stern, L. Z., Sandyk, R., Kennedy, K., & Schram, K. H. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90386-g · Cited by 324

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties

García-Arencibia, M., González, S., de Lago, E., Ramos, J. A., Mechoulam, R., & Fernández-Ruiz, J. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.063 · Cited by 320

Pharmacological characterization of cannabinoids in the elevated plus maze.

Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 312

Cannabidiol in vivo blunts β‐amyloid induced neuroinflammation by suppressing IL‐1β and iNOS expression

Esposito, G., Scuderi, C., Savani, C., Steardo, L., De Filippis, D., Cottone, P., Iuvone, T., Cuomo, V, & Steardo, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707337 · Cited by 308

Effects of cannabidiol (CBD) on regional cerebral blood flow

Crippa, J. A. D. S., Zuardi, A. W., Garrido, G. E. J., Wichert-Ana, L., Guarnieri, R., Ferrari, L., Azevedo-Marques, P. M., Hallak, J. E. C., McGuire, P. K., & Busatto, G. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300340 · Cited by 307

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

Karniol, I. G., Shirakawa, I., Kasinski, N., Pfeferman, A., & Carlini, E. A. (1974) · European Journal of Pharmacology · doi:10.1016/0014-2999(74)90129-0 · Cited by 303

Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. I

ADAMS, R. L. P., Hunt, M., & Clark, J. H. (1940) · Journal of the American Chemical Society · doi:10.1021/ja01858a058 · Cited by 302

Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential

(2003) · Choice Reviews Online · doi:10.5860/choice.40-3432 · Cited by 293

Effect of Δ-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults

Nicholson, A. N., Turner, C., Stone, B. M., & Robson, P. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125688.05091.8f · Cited by 291

Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes

El‐Remessy, A. B., Al‐Shabrawey, M., Khalifa, Y. M., Tsai, N., Caldwell, R. B., & Liou, G. I. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050500 · Cited by 284

Hypnotic and Antiepileptic Effects of Cannabidiol

Carlini, E. A., & Cunha, J. M. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02622.x · Cited by 278

Antitumor Effects of Cannabidiol, a Nonpsychoactive Cannabinoid, on Human Glioma Cell Lines

Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbracchio, M. P., & Parolaro, D. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061002 · Cited by 272

Antipsychotic effect of cannabidiol.

Zuardi, A. W., Morais, S. L., Guimarães, F. S., & Mechoulam, R. (1995) · PubMed · Cited by 264

The marijuana component cannabidiol inhibits β-amyloid-induced tau protein hyperphosphorylation through Wnt/β-catenin pathway rescue in PC12 cells

Esposito, G., Filippis, D. D., Carnuccio, R., Izzo, A. A., & Iuvone, T. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0025-1 · Cited by 252

Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects

Mechoulam, R., & Hanuš, L. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00144-5 · Cited by 250

Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw

Costa, B., Colleoni, M., Conti, S., Parolaro, D., Franke, C., Trovato, A. E., & Giagnoni, G. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0871-3 · Cited by 243

The absolute configuration of δ1-tetrahydrocannabinol, the major active constituent of hashish.

Mechoulam, R., & Gaoni, Y. (1967) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)90646-4 · Cited by 234

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells

McAllister, S. D., Christian, R. T., Horowitz, M. P., García‐Bilbao, A., & Desprez, P. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0371 · Cited by 232

Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22 and Nox4 Expression

McKallip, R. J., Jia, W., Schlomer, J., Warren, J. W., Nagarkatti, P. S., & Nagarkatti, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023937 · Cited by 230

Marihuana, the Forbidden Medicine

Grinspoon, L., & Bakalar, J. B. (1993) · doi:10.1038/scientificamerican1269-17 · Cited by 227

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice

Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S., & Gallily, R. (2005) · Autoimmunity · doi:10.1080/08916930500356674 · Cited by 226

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in β-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-κB involvement

Esposito, G., De Filippis, D., Maiuri, M. C., De Stefano, D., Carnuccio, R., & Iuvone, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.047 · Cited by 225

Cannabidiol Prevents Cerebral Infarction Via a Serotonergic 5-Hydroxytryptamine 1A Receptor–Dependent Mechanism

Mishima, K., Hayakawa, K., Abe, K., Ikeda, T., Egashira, N., Iwasaki, K., & Fujiwara, M. (2005) · Stroke · doi:10.1161/01.str.0000163083.59201.34 · Cited by 225

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Drel, V. R., Obrosova, I. G., & Pacher, P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00236.2007 · Cited by 211

Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test

Moreira, F. A., Aguiar, D. C., & Guimarães, F. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.06.004 · Cited by 207

Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice

Moreira, F. A., & Guimarães, F. S. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.040 · Cited by 206

Discovery and characterization of endogenous cannabinoids

Martin, B. R., Mechoulam, R., & Razdan, R. K. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00281-7 · Cited by 205

Cannabidiol monotherapy for treatment-resistant schizophrenia

Zuardi, A. W., Hallak, J. E. C., Dursun, S. M., Morais, S. L., Sanches, R. F., Musty, R. E., & Crippa, J. A. S. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060967 · Cited by 192

Effects of cannabidiol in animal models predictive of antipsychotic activity

Zuardi, A. W., Antunes Rodrigues, J., & Cunha, J. M. (1991) · Psychopharmacology · doi:10.1007/bf02244189 · Cited by 191

Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells

Srivastava, M. D., Srivastava, B. I. S., & Brouhard, B. H. (1998) · Immunopharmacology · doi:10.1016/s0162-3109(98)00041-1 · Cited by 189

Randomized, Double-Blind, Placebo-Controlled Study About the Effects of Cannabidiol (CBD) on the Pharmacokinetics of Δ9-Tetrahydrocannabinol (THC) After Oral Application of THC Verses Standardized Cannabis Extract

Nadulski, T., Pragst, F., Weinberg, G., Roser, P., Schnelle, M., Fronk, E., & Stadelmann, A. M. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000177223.19294.5c · Cited by 186

Pharmacological interaction between cannabidiol and ?9-tetrahydrocannabinol

Karniol, I. G., & Carlini, E. A. (1973) · Psychopharmacology · doi:10.1007/bf00428793 · Cited by 182

CANNABIS-ASSOCIATED PSYCHOSIS WITH HYPOMANIC FEATURES

Rottanburg, D. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91270-3 · Cited by 177

Cannabidiol Reverses MK-801-Induced Disruption of Prepulse Inhibition in Mice

Long, L. E., Malone, D. T., & TAYLOR, D. A. H. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300838 · Cited by 177

Critical Role of Angiotensin II in Excess Salt-Induced Brain Oxidative Stress of Stroke-Prone Spontaneously Hypertensive Rats

Kim‐Mitsuyama, S., Yamamoto, E., Tanaka, T., Zhan, Y., Izumi, Y., Izumiya, Y., Ioroi, T., Wanibuchi, H., & Iwao, H. (2005) · Stroke · doi:10.1161/01.str.0000163084.16505.e3 · Cited by 173

A comparison of the pharmacological activity in man of intravenously administered 1368-11368-11368-1, cannabinol, and cannabidiol

Perez‐Reyes, M., Timmons, M. C., Davis, K. H., & Wall, E. M. (1973) · Cellular and Molecular Life Sciences · doi:10.1007/bf01922823 · Cited by 161

Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor‐independent mechanism

Vaccani, A., Massi, P., Colombo, A., Rubino, T., & Parolaro, D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706134 · Cited by 154

Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man

Leweke, F. M., Schneider, U., Radwan, M., Schmidt, E., & Emrich, H. M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00201-x · Cited by 150

Open label evaluation of cannabidiol in dystonic movement disorders

Consroe, P. F., Sandyk, R., & Snider, S. R. (1986) · International Journal of Neuroscience · doi:10.3109/00207458608985678 · Cited by 149

Cannabidiol reduced the striatal atrophy caused 3‐nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1and adenosine A2Areceptors

Sagredo, O., Ramos, J. A., Decio, A., Mechoulam, R., & Fernández‐Ruiz, J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05717.x · Cited by 147

Cannabidiol arrests onset of autoimmune diabetes in NOD mice

Weiss, L., Zeira, M., Reich, S., Slavin, S., Raz, I., Mechoulam, R., & Gallily, R. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.06.029 · Cited by 147

Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew)

Parker, L. A., Kwiatkowska, M., Burton, P., & Mechoulam, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1571-2 · Cited by 146

Toward drugs derived from cannabis

Mechoulam, R., & Carlini, E. A. (1978) · Die Naturwissenschaften · doi:10.1007/bf00450585 · Cited by 140

Dorsolateral Prefrontal Cortex N-Acetylaspartate/Total Creatine (NAA/tCr) Loss in Male Recreational Cannabis Users

Hermann, D., Sartorius, A., Welzel, H., Walter, S., Skopp, G., Ende, G., & Mann, K. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.027 · Cited by 135

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury

Durst, R. Y., Danenberg, H. D., Gallily, R., Mechoulam, R., Meir, K., Grad, E., Beeri, R., Pugatsch, T., Tarsish, E., & Lotan, C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00098.2007 · Cited by 134

Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism

Paton, W. D. M., & Pertwee, R. G. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb07261.x · Cited by 134

Analgesic and antiinflammatory activity of constituents ofCannabis sativa L.

Formukong, E. A., EVANS, A. T., & Evans, F. J. (1988) · Inflammation · doi:10.1007/bf00915771 · Cited by 130

Interactions ofΔ 11-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentographywith cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography

Agurell, S., Carlsson, S., Lindgren, J. E., Ohlsson, A., Gillespie, H., & Hollister, L. (1981) · Experientia · doi:10.1007/bf02085029 · Cited by 129

Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents

Carlini, E. A., Leite, J. R., Tannhauser, M., & Berardi, A. C. (1973) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1973.tb10660.x · Cited by 125

Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effects

Dalton, W. S., Martz, R. C., Lemberger, L., Rodda, B. E., & Forney, R. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976193300 · Cited by 123

Cannabidiol and cannabinol in man

Hollister, L. E. (1973) · Cellular and Molecular Life Sciences · doi:10.1007/bf01946311 · Cited by 121

Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats

Murillo‐Rodríguez, E., Millán‐Aldaco, D., Palomero‐Rivero, M., Mechoulam, R., & Drucker-Colı́n, R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.102 · Cited by 116

Effect of cannabidiol and of other Cannabis sativa compounds on hippocampal seizure discharges

Izquierdo, I., Orsingher, O. A., & Berardi, A. C. (1973) · Psychopharmacology · doi:10.1007/bf00413961 · Cited by 111

Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro

Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90160-9 · Cited by 111

Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes.

Doblin, R., & Kleiman, M. A. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.7.1314 · Cited by 110

Reduced binocular depth inversion in schizophrenic patients

Schneider, U., Borsutzky, M., Seifert, J., Leweke, F. M., Huber, T. J., Rollnik, J. D., & Emrich, H. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00172-9 · Cited by 108

Cannabidiol, a non-psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats

Parker, L. A., Mechoulam, R., & Schlievert, C. (2002) · Neuroreport · doi:10.1097/00001756-200204160-00006 · Cited by 105

A metabolic interaction in vivo between cannabidiol and Δ1‐tetrahydrocannabinol

Jones, G., & Pertwee, R. G. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb08092.x · Cited by 97

Pharmacological interaction between cannabinol and ?9-tetrahydrocannabinol

Takahashi, R. N., & Karniol, I. G. (1975) · Psychopharmacology · doi:10.1007/bf00428937 · Cited by 97

Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability

Jacobsson, S. O. P., Rongård, E., Stridh, M., Tiger, G., & Fowler, C. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00492-5 · Cited by 94

Repeated treatment with cannabidiol but not Δ9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance

Hayakawa, K., Mishima, K., Nozako, M., Ogata, A., Hazekawa, M., Liu, A.-X., Fujioka, M., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.11.005 · Cited by 89

Hypnoticlike effects of cannabidiol in the rat

Monti, J. M. (1977) · Psychopharmacology · doi:10.1007/bf00497858 · Cited by 84

Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor‐independent myeloperoxidase‐inhibiting mechanism

Hayakawa, K., Mishima, K., Nozako, M., Hazekawa, M., Irie, K., Fujioka, M., Orito, K., Abe, K., Hasebe, N., Egashira, N., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04565.x · Cited by 84

Interactions in man of delta‐9‐tetrahydrocannabinol; II. Cannabinol and cannabidiol

Hollister, L. E., & Gillespie, H. K. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518180 · Cited by 84

Anticonvulsant effect of cannabidiol.

Fr, A., & Cridland, S. (1986) · PubMed · Cited by 81

Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa

Carlini, E. A., Santos, M., Claussen, U., Bieniek, D., & KORTE, F. (1970) · Psychopharmacology · doi:10.1007/bf00402387 · Cited by 81

Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum

GUIMARAES, V. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.01.015 · Cited by 77

The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat

Rock, E. M., Limebeer, C. L., Mechoulam, R., Piomelli, D., & Parker, L. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0970-1 · Cited by 77

Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers.

Zuardi, A. W., Guimarães, F. S., & Moreira, A. C. (1993) · PubMed · Cited by 76

Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils

Braida, D., Pegorini, S., Arcidiacono, M. V., Consalez, G. G., Croci, L., & Sala, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00569-x · Cited by 73

Modification of ?9-THC-actions by cannabinol and cannabidiol in the rat

Fernandes, M. S., Schabarek, A., Coper, H., & Hill, R. (1974) · Psychopharmacology · doi:10.1007/bf00429130 · Cited by 72

Marihuana: The Forbidden Medicine

Strassman, R. J. (1998) · JAMA · doi:10.1001/jama.279.12.963-a · Cited by 71

Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomiting

PARKER, L., KWIATKOWSKA, M., & Mechoulam, R. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.08.045 · Cited by 67

Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity

Cordier-Dirikoc, S., Priola, S. A., Marella, M., Zsürger, N., & Chabry, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1942-07.2007 · Cited by 63

Anticonvulsant properties of cannabidiol.

Turkanis, S. A., Cely, W., Olsen, D. M., & Karler, R. (1974) · PubMed · Cited by 59

Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism

Hayakawa, K., Mishima, K., Abe, K., Hasebe, N., Takamatsu, F., Yasuda, H., Ikeda, T., Inui, K., Egashira, N., Iwasaki, K., et al. (2004) · Neuroreport · doi:10.1097/00001756-200410250-00016 · Cited by 56

The content of (-)Δ9-trans-tetrahydrocannabinol (Δ9-THC) does not explain all biological activity of some Brazilian marihuana samples

Karniol, I. G., & Carlini, E. A. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08897.x · Cited by 44

Stimulus Characteristics of Marihuana Components

Kubena, R. K., & Barry, H. (1972) · Nature · doi:10.1038/235397a0 · Cited by 39

Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.

Zuardi, A. W., & Karniol, I. G. (1983) · PubMed · Cited by 38

Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.

Aw, Z., Finkelfarb, E., Bueno, O. F., Musty, R. E., & Karniol, I. G. (1981) · PubMed · Cited by 36

Comparative effects between cannabidiol and diazepam on neophobia food intake and conflict behavior

Filho, N. G. S., & Tufik, S. B. (1981) · Research communications in psychology, psychiatry and behavior · Cited by 36

Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.

Zuardi, A. W., Teixeira, N. A. A., & Karniol, I. G. (1984) · PubMed · Cited by 35

Cannabidiol and δ9-tetrahydrocannabinol metabolism

Borys, H. K., & Karler, R. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90472-6 · Cited by 23

The pharmacological actions of cannabidiol

Long, L. E., Malone, D. T., & TAYLOR, D. A. H. B. (2005) · Drugs of the Future · doi:10.1358/dof.2005.030.07.915908 · Cited by 20

Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior.

Davis, W. M., & Borgen, L. A. (1974) · PubMed · Cited by 19

Changes in the conditioned emotional response of rats, induced by delta 9-thc, cbd and mixture of the two cannabinoids

Zuardi, A. W., & Karniol, I. G. (1983) · Cited by 16

Cannabidiol interaction with delta9-tetrahydrocannabinol.

Borgen, L. A., & Davis, W. M. (1974) · PubMed · Cited by 12

Cannabidiol and its pharmacokinetic interaction withδ 1-Tetrahydrocannabinol

Levy, S., & McCallum, N. K. (1975) · Cellular and Molecular Life Sciences · doi:10.1007/bf01945772 · Cited by 8

Adverse health effects of marijuana use.

Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb

Izzo, A. A., Borrelli, F., Capasso, R., Marzo, V. D., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 879

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

Bergamaschi, M. M., Queiroz, R. H. C., Chagas, M. H. N., de Oliveira, D. C. G., De Martinis, B. S., Kapczinski, F., Quevedo, J., Roesler, R., Schröder, N., Nardi, A. E., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.6 · Cited by 771

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680

Safety and side effects of cannabidiol, a Cannabis sativa constituent

Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558

Historical perspective on the therapeutic potential of cannabidiol

Guimarães, F. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.03.008 · Cited by 4

Cannabidiol: brief compilation over a versatile molecule

de Paula, C. B. C. O., Baldacci, E. A., Cheng, L. C., Gozzi, M. B., Shibuya, P. T., Nicolau, L. A. D., Medeiros, J. V. R., Anghinah, R., de Oliveira, J. V., Gehrke, F. D. S., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i14.22239 · Cited by 2

THERAPEUTIC POTENTIAL OF CANNABIDIOL: THE MOST IMPORTANT ACHIEVEMENTS ON THE WAY TO A NEW ERA

Shevchuk, M. M., & Volos, L. I. (2023) · Medical Science of Ukraine (MSU) · doi:10.32345/2664-4738.2.2023.17 · Cited by 5

Analogues and Derivatives of Cannabidiol: Pharmacological Insights and Recent Efforts in the Search for Novel Drug Candidates for Inflammation and Pain - a Brief Review Over the Past 3 Decades

de Souza, M. L., Franco, G. R. R., Massuda, L. E., Gontijo, V. S., & Viegas, C. (2024) · Journal of the Brazilian Chemical Society · doi:10.21577/0103-5053.20240155

Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.

Burstein, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.059 · Cited by 573